Prescription drug · ANDA
Hydroxyurea NDC 70954-824
Hydroxyurea 1000 mg/1 · Tablet, Film coated · Oral · ANI Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70954-824-10 | 7095408241070954082410 | 30 TABLET, FILM COATED in 1 BOTTLE (70954-824-10)Marketed from Nov 10, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Hydroxyurea
- Generic name (nonproprietary)
- hydroxyurea
- Active ingredients
- Hydroxyurea — 1000 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- ANI Pharmaceuticals, Inc.NDC labeler code 70954
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 220300
- Marketing start
- Listing expires
- Other FDA classes
- Urea (Chemical structure)
- Identifiers
- Product ID 70954-824_f7b8cae7-7f38-4c17-a9e2-fc123c102e0cSPL ID f7b8cae7-7f38-4c17-a9e2-fc123c102e0cSPL set ID f7b8cae7-7f38-4c17-a9e2-fc123c102e0cUNII X6Q56QN5QC
- Pharmacologic class
- Antimetabolite
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470954082410followed by a unit qualifier and the quantityPackage 70954-0824-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Hydroxyurea tablets are indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in adult and pediatric patients, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises. Hydroxyurea tablets is an antimetabolite, indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in adult and pediatric patients, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises. (1)
Excerpt only. Read the full label for complete information.
About NDC 70954-824
- What is NDC 70954-824?
- 70954-824 is the product NDC for Hydroxyurea, Hydroxyurea 1000 mg/1 tablet, film coated, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Hydroxyurea.
- What is the active ingredient?
- Hydroxyurea.
- Who is the labeler?
- ANI Pharmaceuticals, Inc., NDC labeler code 70954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Hydroxyurea?
- 9 other product NDCs are listed under this name. See all Hydroxyurea NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Hydroxyurea products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Hydroxyurea | Hydroxyurea 500 mg/1 | CapsuleOral | Coupler LLC | 67046-1619 | 67046-1619-03 |
| Hydroxyurea | Hydroxyurea 500 mg/1 | CapsuleOral | Somerset Therapeutics, LLC | 70069-820 | 70069-0820-01 |
| Hydroxyurea | Hydroxyurea 500 mg/1 | CapsuleOral | Qilu Pharmaceutical Co., Ltd. | 67184-0607 | 67184-0607-01 |
| Hydroxyurea | Hydroxyurea 500 mg/1 | CapsuleOral | Leading Pharma, LLC | 69315-164 | 69315-0164-01 |
| Hydroxyurea | Hydroxyurea 500 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-909 | 51407-0909-01 |
| Hydroxyurea | Hydroxyurea 500 mg/1 | CapsuleOral | AvKARE | 42291-321 | 42291-0321-01 |
| Hydroxyurea | Hydroxyurea 500 mg/1 | CapsuleOral | American Health Packaging | 68084-284 | 68084-0284-01 |
| Hydroxyurea | Hydroxyurea 500 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-6939 | 00904-6939-61 |
| Hydroxyurea | Hydroxyurea 500 mg/1 | CapsuleOral | Par Health USA, LLC | 49884-724 | 49884-0724-01 |
| Hydroxyurea | Hydroxyurea 500 mg/1 | CapsuleOral | Teva Pharmaceuticals USA, Inc. | 0555-0882 | 00555-0882-02 |
Other NDCs under ANDA 220300
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Hydroxyurea | Hydroxyurea 100 mg/1 | Tablet, Film coatedOral | ANI Pharmaceuticals, Inc. | 70954-823 |